How does PAOG's PB Ratio compare to its peers?

Insufficient data to calculate PAOG's Price-To-Book Ratio vs. peers for valuation analysis.

How does PAOG's PB Ratio compare vs other companies in the US Pharmaceuticals Industry?

Insufficient data to calculate PAOG's Price-To-Book Ratio vs. industry for valuation analysis.

What is PAOG's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate PAOG's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of PAOG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate PAOG's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

PAO Group (OTCPK:PAOG) - Stock Price, News & Analysis

PAOG Stock Overview

Focuses on alternative patient care treatments. More details

PAOG fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap ($573K)

Highly volatile share price over the past 3 months compared to the US market

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

PAO Group, Inc. Competitors

AmeriCann

OTCPK:ACAN

US$683.0k

Altamira Therapeutics

OTCPK:CYTO.F

US$452.2k

Universe Pharmaceuticals

NasdaqCM:UPC

US$407.8k

CBD Life Sciences

OTCPK:CBDL

US$1.5m

Price History & Performance

Summary of share price highs, lows and changes for PAO Group
Historical stock prices
Current Share Price	US$0.0002
52 Week High	US$0.0022
52 Week Low	US$0.0002
Beta	0
1 Month Change	-33.33%
3 Month Change	-33.33%
1 Year Change	-90.00%
3 Year Change	-90.00%
5 Year Change	-60.00%
Change since IPO	-100.00%

Recent updates

Shareholder Returns

	PAOG	US Pharmaceuticals	US Market
7D	-33.3%	0.1%	-0.5%
1Y	-90.0%	0.6%	21.1%

Return vs Industry: PAOG underperformed the US Pharmaceuticals industry which returned 1.4% over the past year.

Return vs Market: PAOG underperformed the US Market which returned 23.1% over the past year.

Price Volatility

Is PAOG's price volatile compared to industry and market?
PAOG volatility
PAOG Average Weekly Movement	39.3%
Pharmaceuticals Industry Average Movement	10.0%
Market Average Movement	5.9%
10% most volatile stocks in US Market	18.2%
10% least volatile stocks in US Market	3.0%

Stable Share Price: PAOG's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: PAOG's weekly volatility has increased from 34% to 39% over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Jim DiPrima	www.pao.group

PAO Group, Inc. focuses on alternative patient care treatments. The company, through its subsidiaries, engages in the development, sale, and distribution of premium medical cannabis products for treatment of chronic and terminal patients. The company is headquartered in Sandusky, Ohio.

PAO Group, Inc. Fundamentals Summary

How do PAO Group's earnings and revenue compare to its market cap?
PAOG fundamental statistics
Market cap	US$573.06k
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is PAOG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PAOG income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did PAOG perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/12 18:43
End of Day Share Price	2025/02/12 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PAO Group, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.